Lobbying client

SEBELA PHARMACEUTICALS

Developing therapies for gastrointestinal diseases and women's health

Filings
14
Filed by
1
Reported in-house
—
Reported by firms
$480,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2023 to 2026

Filings

14 filings, newest first.
Filing Filed by Amount
2nd Quarter - Report (No Activity)
2nd Quarter 2024
THE KPM GROUP DC LLC $40,000 reported
1st Quarter - Report (No Activity)
1st Quarter 2024
THE KPM GROUP DC LLC $40,000 reported
4th Quarter - Report (No Activity)
4th Quarter 2023
THE KPM GROUP DC LLC $40,000 reported
Registration
4th Quarter 2023
THE KPM GROUP DC LLC — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
THE KPM GROUP DC LLC 12 $480,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 9

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.